Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Adult ID, Pediatric ID
Presentations:
Evaluation of Moderate-to-Severe Influenza Disease in Children 6 months to 8 years of age in Colorado
Suchitra Rao, MBBS;
Molly Lamb, PhD;
Angela Moss, MS;
Emad Yanni, MD, MSC;
Rafik Bekkat-Berkani, MD;
Anne Schuind, MD;
Bruce Innis, FIDSA;
Jillian Cotter, MD;
Rakesh Mistry, MD;
Edwin J. Asturias, MD
Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study
Wendy Daly, MD;
Keith Ramsey, DO;
Aino Forsten, MD;
Esther Heijnen, MD, PhD;
Brett Leav, MD;
Janine Oberye, MSc;
Bin Zhang, ScD;
Filippo Pacciarini, PhD;
Timo Vesikari, MD, PhD
Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010-2018
Brendan L. Flannery, PhD;
Jessie Chung, MPH;
Michael L. Jackson, PhD, MPH;
Lisa A. Jackson, MD, MPH, FIDSA;
Arnold S. Monto, MD, FIDSA;
Emily T. Martin, MPH, PhD;
Edward Belongia, MD;
Huong McLean, PhD, MPH;
Richard K. Zimmerman, MD MPH, FIDSA;
Mary Patricia Nowalk, PhD RD;
Manjusha Gaglani, MBBS;
Marie R. Griffin, MD, MPH;
H. Keipp Talbot, MD, MPH;
John J. Treanor, MD;
Sarah Spencer, PhD;
Alicia M. Fry, MD, MPH
Randomized Trial of High Dose, Adjuvanted, and Standard Inactivated Influenza Vaccine Immune Response Against Egg- and Cell-propagated Vaccine Strains in Older Adults, 2016-17 Season
Huong McLean, PhD, MPH;
Min Levine, PhD;
Jennifer King, MPH;
Sarah Spencer, PhD;
Brendan Flannery, PhD;
Edward Belongia, MD
2016/2017 Influenza Burden of Disease and End-of-Season Influenza Vaccine Effectiveness (VE) Estimates for Preventing Influenza-Related Hospitalization Among Canadian Adults: An Analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network
Michaela Nichols, MSc;
Melissa K Andrew, MD, PhD;
Todd F Hatchette, MD FRCPC;
Ardith Ambrose, RN;
Guy Boivin, MD, MSc;
May Elsherif, MD;
Karen Green, MSc, RN;
Jennie Johnstone, MD, PhD;
Kevin Katz, MD, CM, MSc, FRCPC;
Jason Leblanc, PhD;
Mark Loeb, MD, MSc;
Donna Mackinnon-Cameron, MMath;
Anne Mccarthy, MD;
Janet McElhaney, MD;
Allison McGeer, MD, MSc;
Andre Poirier, MD, MSc;
Jeff Powis, MD, MSc, FRCPC;
David Richardson, MD;
Makeda Semret, MD;
Daniel Smyth, MD, FRCPC;
Sylvie Trottier, MD, PhD;
Louis Valiquette, MD, MSc, FRCPC;
Duncan Webster, MD;
Lingyun Ye, MSc;
Shelly A McNeil, MD, FIDSA
AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Peripheral Blood Mononuclear Cells
Leigh Howard, MD, MPH;
Johannes Goll, M.S.;
Travis Jensen, B.S.;
Heather Hill, MS;
Casey Gelber, MS;
C. Buddy Creech, MD, MPH, FPIDS;
Kathryn Edwards, MD, FIDSA
Effectiveness of influenza vaccine for prevention of influenza-associated hospitalizations among high-risk adults in the U.S., 2015 – 2016
Elif Alyanak, MPH;
Manjusha Gaglani, MBBS;
Emily T. Martin, MPH, PhD;
Arnold S. Monto, MD, FIDSA;
Don Middleton, MD;
Fernanda P. Silveira, MD, MS;
Richard Zimmerman, MD, MPH;
H. Keipp Talbot, MD, MPH;
Jill M. Ferdinands, PhD, MSc
A cluster-randomized trial of adjuvanted trivalent influenza vaccine vs. standard dose in U.S. nursing homes
Stefan Gravenstein, MD, MPH;
H. Edward Davidson, PharmD, MPH;
Kevin Mcconeghy, Pharm.D.;
Lisa Han, MPH;
David Canaday, MD;
Elie Saade, MD, MPH;
Rosa R. Baier, MPH;
Vincent Mor, PhD
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
